Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for BRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
March 31, 2026 4.640M
December 31, 2025 4.080M
September 30, 2025 5.643M
June 30, 2025 8.517M
March 31, 2025 10.33M
December 31, 2024 12.28M
September 30, 2024 14.57M
June 30, 2024 16.12M
March 31, 2024 17.95M
December 31, 2023 12.61M
September 30, 2023 13.80M
June 30, 2023 13.30M
March 31, 2023 14.08M
December 31, 2022 16.43M
September 30, 2022 17.92M
June 30, 2022 19.44M
March 31, 2022 20.92M
December 31, 2021 22.45M
September 30, 2021 2.175M
June 30, 2021 2.885M
March 31, 2021 3.701M
December 31, 2020 4.347M
September 30, 2020 1.429M
June 30, 2020 1.613M
March 31, 2020 1.378M
Date Value
December 31, 2019 1.466M
September 30, 2019 1.458M
June 30, 2019 2.432M
March 31, 2019 1.584M
December 31, 2018 1.192M
September 30, 2018 1.251M
June 30, 2018 1.206M
March 31, 2018 1.223M
December 31, 2017 1.759M
September 30, 2017 1.419M
June 30, 2017 1.424M
March 31, 2017 1.480M
December 31, 2016 1.58M
September 30, 2016 1.617M
June 30, 2016 2.196M
March 31, 2016 2.050M
December 31, 2015 2.017M
September 30, 2015 2.151M
June 30, 2015 2.071M
March 31, 2015 1.858M
December 31, 2014 1.692M
September 30, 2014 1.596M
June 30, 2014 1.186M
March 31, 2014 1.253M
December 31, 2013 1.383M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. 638.90M
CareDx, Inc. 532.99M
Natera, Inc. 2.657B
Exagen, Inc. 51.94M
Sera Prognostics, Inc. 86.74M

Total Assets (Quarterly) Related Metrics